NOT KNOWN FACTUAL STATEMENTS ABOUT OTAMIXABAN

), allows to explain why KIF15 will be able to facilitate resistance to Eg5 inhibitors in vivo. MT gliding driven by each of those mitotic motors was arrested only when they ended up independently inhibited, lending assist to the proposal that a mix drug therapy targeting these motors may be a workable system for overcoming chemotherapeutic resista